课题基金 / 基金详情

ENANTIOMERIC RESOLUTION OF RACEMIC IBUPROFEN IN SUPERCRITICAL CO2

ENANTIOMERIC RESOLUTION OF RACEMIC IBUPROFEN IN SUPERCRITICAL CO2
超临界 CO2 中外消旋布洛芬的对映体拆分
批准号:
2765207
负责人:
金额:
$0.08万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
A common NSAID, ibuprofen, is marketed as a racemic mixture. It's optically active isomer however, is more commercially valuable particularly to the pharmaceutical industry. Within the past few years investigators have been able to separate the enantiomers by traditional crystallization techniques using L-lysine as a resolving agent. This process, though successful, is time consuming because it is dependent upon crystal formation. The use of supercritical fluids affords a potential means to quick and inexpensive resolution. We have developed a resolving agent suitable for a supercrititcal carbon dioxide medium. Through preliminary molecular modeling studies using a augmented form of Allinger's MM3 force field, this agent appears sufficiently selective for the enantiomers of ibuprofen on a theoretical basis. We have synthesized and characterized our resolving agent, which is a fluorinated L-lysine derivative. Our attempts and theoretical expectations of enantiomeri ibup rofen separations in supercritical carbon dioxide will be related to the effectiveness of chiral amino acid systems in non-traditional media.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金